Naringenin |
HBV |
Infectivity of viruses in the host cell by targeting viral envelope by reverse transcriptases |
Alam et al. (2017) |
HCV |
Reduction in lipid profile and liver enzyme aspartate transaminase with a decreased infectivity and spread of infection |
Goncalves et al. (2017) |
DENV‐1,2,3 & 4 |
Reduction in Huh‐7.5 DENV‐1 infected cells and CD14+ cells in human PBMCs |
Frabasile et al. (2017) |
DENV‐2 |
50% of reduction in viral RNA infection |
Zandi et al. (2011) |
ZIKV |
Reduction in the number of infected hmd‐DCs by impairing the viral replication |
Cataneo et al. (2019) |
HCV |
Minimum binding energy with NS2 protease and target protein for antiviral activity were analysed by in silico method |
Sajitha Lulu et al. (2016) |
CHIKV |
Production of viral proteins was prevented in a host cell by which leads to killing 50% of infected cells |
Ahmadi et al. (2016) |
NSV |
80% of viral replication was inhibited by blocking the infectivity |
Paredes et al. (2003) |
HCV |
70% of inhibition in the secretion of HCV core and HCV RNA which leads to inhibition of apoB100‐dependent HCV secretion |
Nahmias et al. (2008) |
HCV |
Assembly of infectious HCV particles blocked by activating the peroxisome proliferator‐activated receptor‐α and reduction in VLDL production |
Goldwasser et al. (2011) |
Mangiferin |
HSV‐1 |
56.8% of plaque reduction was observed with decreased viral replication |
Zheng and Lu (1990) |
HIV |
The significant cytopathic effect in infected cells |
Guha et al. (1996) |
Poliovirus |
Increased virulence and replication of the virus in host cells was observed in different stages of poliovirus |
Rechenchoski et al. (2018) |
HSV‐2 |
Viral replication was significantly reduced with decreased plaque formation in HeLa cells |
Zhu et al. (1993) |
HIV‐1IIIB & HIV‐1RF |
The inhibitory activity is effective against peptidic protease inhibitor‐resistant strains in lower concentrations |
Wang et al. (2011) |
Isomangiferin |
HSV‐1 |
69.5% of plaque reduction with decreased viral replication |
Zheng et al. (1990) |
α‐Mangostin |
HIV‐1 |
Significant inhibitory activity with decreased viral replication |
Chen et al. (1996) |
DENV‐2 |
Viral replication was reduced by more than 50% and increased gradually by post‐infection |
Sugiyanto et al. (2019) |
DENV‐1,2,3 & 4 |
The infection rate was reduced by 47%–55% by inhibiting the cytokine and chemokine transcription |
Tarasuk et al. (2017) |
Geraniin |
DENV‐2 |
100% inhibition of viral replication was noticed by preventing the viral attachment at early stages of infection |
Abdul Ahmad et al. (2017) |
EV71 |
Addition of geraniin at 2 hr post EV71 infection on human rhabdomyosarcoma cells inhibited infectious virus yield and viral RNA replication |
Yang, Zhang, et al. (2012) |
Geraniin significantly enhanced the survival rate of EV71 infected mice and decreased viral replication in muscle tissues |
Yang, Zhang, et al. (2012) |
DENV‐1,2 |
The compound inhibited the replication of HSV‐2 with an IC50 and IC90 of 18.4 ± 2.0 and 37.6 ± 2.3 µM, respectively, and inhibited the replication of HSV‐1 with an IC50 of 35.0 ± 4.2 µM. |
Yang et al. (2007) |
HIV‐1 |
Significant inhibitory effect against the replication of HIV‐1 showed with IC50 and EC50 of 1.8 ± 0.5 µg/ml and 0.24 ± 0.10 µg/ml respectively in MAGI cells |
Notka et al. (2003) |
The significant anti‐HIV activity was recorded in CD4+ lymphoid cells MT4 at even low concentrations |
Notka et al. (2003) |
Punicalagin |
EV71 |
Viral replication was inhibited with reduced cytopathic effect on rhabdomyosarcoma cells |
Yang, Zhang, et al. (2012) |
HSV‐1 |
Viral infectivity and replication were reduced 8‐fold with no toxicity |
Houston et al. (2017) |
HSV‐2 |
100% inhibition of viral infection was recorded in Hep‐2 cells of human epithelial tissue |
Arunkumar and Rajarajan (2018) |
HBV |
Punicalagin down regulated the level of cccDNA formation in HBV without inhibiting viral RNA transcription and DNA replication in the host cells. |
Liu et al. (2016) |
IFV‐A |
The compound significantly inhibiting the agglutination of chicken RBCs in the IFV‐A and prevents the proliferation of IFV‐A in both single and multiple cycle growth conditions in infected MDCK cells |
Haidari et al. (2009) |
(2R, 4R)‐1,2,4‐trihydroxyheptadec‐16‐one |
DENV‐1,2,3 & 4 |
The survival rate of DENV infected mice was increased by stimulating the NF‐κB‐ mediated IFN responses with no cytotoxicity |
Wu et al. (2019) |
BanLec (Banana lectin) |
HIV‐1 |
Attachment of virus into the host cell was prevented in very low concentrations |
Mazalovska and Kouokam (2018) |
HIV |
Mitogenicity and significant antiviral properties were observed |
Swanson et al. (2015) |
Influenza A, B |
Engineered BanLec exhibited antiviral activity at 10 μg/ml |
Covés‐Datson et al. (2020) |
HIV |
Penetration of viral particles and viral envelopes into the host cells was observed with less toxicity |
Akkouh et al. (2015) |
HIV |
Inhibition of viral entry into the host cell and spread of infection was reduced by binding to the glycosylated viral envelope |
Swanson et al. (2010) |
Jacalin (Jackfruit lectin) |
HIV‐1 |
Inhibition of viral replication by binding to membrane molecules together with CD4 |
Favero et al. (1993) |
HSV‐2, VZV, hCMV |
50% of inhibition and viral replication was noticed with mitogenic action for NK lymphocyte |
Wetprasit et al. (2000) |
Lectin like compounds (Japanese plum) |
H1N1, H3N2 |
Prevents the attachment of viral haemagglutination in host MDCK cells before viral adsorption |
Yingsakmongkon et al. (2008) |
Betacyanin (Fractions) |
DEN‐V |
95% of viral replication and infection was inhibited with no cytotoxicity |
Chang et al. (2020) |
Marmelide |
Coxsackievirus B3 |
Loss of infectivity was observed with inactivating the viruses at 125 µg/ml for 1 hr at 37℃ |
Badam et al. (2002) |